UPSTREAM PROCESSING FEATURED ARTICLES

Computational Science: Disruption In Biopharma Discovery How Computational Drug Discovery Is Disrupting Biopharma

NeuBase Therapeutics CEO Dr. Dietrich Stephan discusses the important role computational drug discovery plays as we emerge from what he characterizes as “a decades-long, multi-billion-dollar chemical engineering escapade with a very low success rate to find one drug.

  • Beating Stem Cell Sourcing, Exosome Production Challenges

    Urgent medical needs like COVID-19 therapeutics are fueling new interest in cell-based therapies, despite a years-long, uphill social battle. Here’s how one company’s persistent, global pursuit of safely harvested biologics is positioning it to address the greatest medical need of our time. 

  • Introducing The Business Of Biotech Podcast

    BioProcess Online is proud to launch The Business Of Biotech, a podcast series dedicated to the leaders of new and emerging biopharma firms as a resource on their journey from drug discovery to success in the clinic. Here's a preview of our first season, stacked with insight from founders who have done just that. 

  • Abcentra Chief Looks Beyond The Clinical Horizon

    Why Bert Liang, M.D., Ph.D. obsesses over at-scale manufacturing and regulatory challenges from the outset of clinical trials. 

UPSTREAM PROCESSING WHITE PAPERS & CASE STUDIES

UPSTREAM PROCESSING PRODUCTS

ÄKTA avant™ is a preparative chromatography system designed for fast and secure development of scalable methods and processes.

Mixed-mode chromatography resin is a top tier selection for the manipulation, purification and handling of molecules; providing an unmatched level of separation properties and resolution. The combination of cation exchange resin and metal affinity resin properties, allows multimodal chromatography to provide an access route for biomolecules to separate and the use of alternative chromatographic methods make these biomolecules seem homogenous.

The S.U.F. is engineered for optimal oxygen mass transfer, mixing, and temperature control, and performs comparably to traditional stainless steel systems. Using traditional, fundamental engineering principles, scale-up and process development work is streamlined – offering you cost savings and efficiency. 
 

In an effort to push science forward, WHEATON is manufacturing  a new line of membrane driven flasks for high density cell culture. The flasks are designed to enhance small scale bio-production for antibody and protein generation.

Macro-Prep hydrophobic interaction chromatography (HIC) media are methacrylate-based, 50 µm beads used for protein, polypeptide, enzyme, and nucleic acid purification.

Macro-Prep hydrophobic interaction chromatography (HIC) media are methacrylate-based, 50 µm beads used for protein, polypeptide, enzyme, and nucleic acid purification.

Resin are designed specifically for intermediate purification steps that remove host-cell contaminants from partially purified targets using strong or weak hydrophobic interactions. Methacrylate-based beads for protein and nucleic acid purification using hydrophobic interactions are available for purifying compounds that have weak or strong hydrophobic regions.

To say that the AvaSpec-Micro spectrometer is small would be a huge understatement. This miniature spectrometer measures in at only 62 x 42 x 14.8 mm and weighs only 58 grams. It’s ideal for OEMs that need to comply with space and weight reduction constraints in color measurement, chemical analysis, and environmental analysis applications.

UPSTREAM PROCESSING MULTIMEDIA

The Infinite® 200 PRO NanoQuant was the first microplate reader to be developed specifically for absorbance applications with small sample size. The following video demonstrates the easy handling of this versatile instrument.
 

At INTERPHEX 2012, John Rouen discusses the challenge of conductivity – primarily to provide a stable measurement. It’s important that the customer provides clean water to their products.

High throughput experimentation (HTE) was used in this case study in concert with DOE methodology to study the mass recovery of a basic therapeutic protein (pI 9.2-9.5) using a hydrophobic cation exchange mixed mode resin.

UPSTREAM PROCESSING INDUSTRY NEWS